JHS Svendgaard Laboratories
add_icon

JHS Svendgaard Laboratories

9.90
-0.08
(-0.80%)
Market Cap
84.75 Cr
PE Ratio
-16.34
Volume
85,495.00
Day High - Low
10.18 - 9.72
52W High-Low
16.46 - 8.66
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
84.75 Cr
EPS
-2.37
PE Ratio
-16.34
PB Ratio
0.49
Book Value
20.49
EBITDA
-1.10
Dividend Yield
0.00 %
Return on Equity
-11.43
Debt to Equity
0.03
Forecast For
Actual

Company News

View All News
Caret
neutral
JHS Svendgaard Laboratories reported no deviation in utilization of Rs. 29.99 crores raised through preferential issue for Q3FY26, with funds allocated across manufacturing facility equipment and group entity expansion.
positive
JHS Svendgaard Laboratories completed conversion of 18,01,801 warrants into equity shares at Rs. 27.75 each, raising Rs. 3.75 crore from Coeus Global Opportunities Fund through preferential allotment.
positive
JHS Svendgaard Laboratories' Nomination and Remuneration Committee approved the grant of 31,30,000 employee stock options convertible into equal equity shares of Rs. 10 face value each under its Employee Stock Option Scheme-2025. The options carry an exercise price of Rs. 10 per option with a vesting period starting one year from grant date and extending up to five years, providing eligible employees with potential equity participation in the company.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,205.90
#1 1,23,393.06
66.72
#1 14,680.40
2.19
#1 1,852
-0.08
52.75
509.70
90,404.99
48.89
13,113.20
1.76
1,740
7.33
48.85
2,197.90
59,779.72
44.42
6,179.00
7.33
1,437
0.34
58.91
11,501.00
37,333.09
43.45
3,411.80
-19.87
637
12.25
31.05
8,444.50
27,516.59
44.69
2,262.80
-14.91
418
36.90
48.52
479.60
20,934.54
#1 26.91
3,877.30
6.96
803
14.52
37.54
425.35
11,419.25
133.47
203.20
#1 13.97
41
#1 195.50
52.06
300.80
9,787.12
63.87
2,145.70
8.94
73
93.08
61.14
383.00
5,002.68
30.64
1,000.40
-2.76
125
83.40
67.18
711.00
1,285.96
82.41
77.10
-
16
-
34.42
Growth Rate
Revenue Growth
26.36 %
Net Income Growth
380.49 %
Cash Flow Change
43.57 %
ROE
378.24 %
ROCE
295.91 %
EBITDA Margin (Avg.)
-126.44 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
21
22
25
25
26
24
31
23
28
55
32
45
40
21
32
39
39
27
38
39
49
19
32
28
30
24
26
24
22
23
24
23
29
16
19
17
23
25
21
23
27
25
23
24
Expenses
29
22
24
24
41
22
28
19
24
26
28
39
34
20
31
36
38
26
36
36
50
20
29
25
25
22
24
22
19
23
23
24
44
18
19
14
21
23
21
22
33
22
21
22
EBITDA
-7
-0
2
1
-15
2
3
4
3
29
4
6
6
1
1
3
0
2
2
3
-1
-1
3
3
4
2
3
2
2
0
1
-1
-15
-2
1
2
2
2
0
1
-7
3
2
2
Operating Profit %
-37 %
-1 %
6 %
4 %
-62 %
8 %
10 %
15 %
12 %
5 %
11 %
11 %
10 %
-0 %
-3 %
10 %
-9 %
-1 %
-0 %
1 %
-22 %
-17 %
9 %
7 %
0 %
-3 %
5 %
-5 %
-1 %
-7 %
-9 %
-10 %
-102 %
-13 %
2 %
-0 %
4 %
8 %
-4 %
1 %
-33 %
7 %
4 %
7 %
Depreciation
2
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
2
2
2
2
2
2
2
2
2
2
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-9
-2
-1
-2
-18
0
1
2
2
28
3
4
4
-1
-1
1
-2
-1
-1
0
-4
-3
1
0
3
-0
1
-0
-0
-2
-1
-3
-17
-3
-1
1
0
0
-2
-2
-9
1
0
0
Tax
0
0
0
0
0
0
0
0
-17
9
1
2
1
-0
-0
1
-1
-0
1
-0
-1
-1
0
0
-0
0
0
-0
4
2
-0
-0
-6
-1
-0
1
1
1
8
0
-2
-0
0
-1
Net Profit
-9
-2
-1
-2
-18
0
1
2
19
19
2
3
3
-1
-1
1
-1
-1
-2
0
-3
-3
1
0
3
-0
1
0
-4
-4
-1
-3
-11
-3
-1
0
-1
-1
-10
-2
-7
1
-0
1
EPS in ₹
-3.74
-0.63
-0.38
-0.64
-6.87
0.08
0.34
0.45
4.61
3.71
0.34
0.45
0.50
-0.09
-0.17
0.10
-0.02
-0.05
-0.09
0.11
-0.30
-0.41
0.16
0.02
0.44
-0.02
0.04
0.04
-0.68
-0.59
-0.11
-0.24
-1.37
-0.33
-0.09
0.00
-0.10
-0.08
-1.24
-0.21
-0.84
0.12
-0.02
0.09

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
170
121
155
208
221
241
228
222
228
197
201
Fixed Assets
108
65
65
71
71
66
63
59
65
90
90
Current Assets
43
36
43
103
102
130
121
79
85
44
54
Capital Work in Progress
0
1
1
1
5
7
9
20
9
1
0
Investments
0
0
1
18
10
6
2
4
3
3
4
Other Assets
62
55
89
118
136
162
154
140
152
102
107
Total Liabilities
170
121
155
208
221
241
228
222
228
197
201
Current Liabilities
49
18
20
32
39
48
23
19
37
23
25
Non Current Liabilities
1
2
1
2
2
8
7
8
18
4
4
Total Equity
120
101
134
174
181
185
198
195
174
170
173
Reserve & Surplus
96
57
86
113
116
117
124
121
95
92
85
Share Capital
24
38
44
61
61
61
64
65
78
78
86

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-1
2
3
0
-5
-0
20
-16
32
-28
-2
Investing Activities
1
2
-3
-27
-7
-11
-2
-5
10
-21
-20
Operating Activities
7
-4
-4
14
-11
10
12
-9
23
-9
-5
Financing Activities
-10
4
10
14
13
1
10
-2
-1
2
23

Share Holding

% Holding
Feb 2021
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Feb 2026
Promoter
41.77 %
41.77 %
41.77 %
41.77 %
41.77 %
42.23 %
42.23 %
42.23 %
42.23 %
42.23 %
42.23 %
37.73 %
37.73 %
37.73 %
37.73 %
34.56 %
34.56 %
34.56 %
34.56 %
34.56 %
34.56 %
34.56 %
33.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.30 %
0.15 %
0.00 %
1.69 %
1.59 %
1.60 %
1.59 %
1.57 %
1.57 %
3.60 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
6.21 %
6.05 %
3.84 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
46.52 %
47.04 %
48.16 %
48.94 %
47.90 %
48.01 %
48.24 %
48.15 %
47.29 %
48.48 %
46.35 %
39.86 %
40.04 %
42.75 %
42.51 %
42.06 %
46.53 %
47.05 %
46.91 %
47.00 %
47.30 %
47.59 %
46.63 %
Others
11.71 %
11.20 %
10.08 %
9.29 %
10.33 %
9.75 %
9.53 %
9.62 %
10.48 %
9.29 %
11.41 %
22.41 %
22.22 %
11.02 %
13.56 %
19.55 %
17.22 %
16.80 %
16.93 %
16.85 %
16.57 %
16.29 %
15.93 %
No of Share Holders
0
20,386
20,018
21,817
25,373
25,155
24,754
24,317
24,305
24,308
23,800
22,800
22,648
26,448
25,768
25,591
25,994
26,276
25,567
25,155
25,007
25,151
25,377

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
04 Jul 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
04 Jul 2024 20.85 22.48
10 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
10 Sept 2024 21.99 30.19
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 25.89 23.95
11 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2025 19.58 18.39
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 14.03 13.96
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 11.48 11.79
20 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2025 10.54 11.18
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 12.49 11.55
10 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2026 11.29 11.13

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulation 2015 For The Quarter Ended December 31 202510 days ago
Appointment Of Internal Auditors10 days ago
Board Meeting Outcome for Un-Audited Financial Results For The Quarter And Nine Month Ended 31St December 202510 days ago
Un- Audited Financial Result For The Quarter Ended 31St December 202510 days ago
Intimation Of Grant Of ESOP10 days ago
Board Meeting Intimation for The Un-Audited Financial Statement For Quarter And Nine Months Ended 31 December 2025.Feb 04, 2026
Announcement under Regulation 30 (LODR)-AllotmentFeb 01, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Closure of Trading WindowDec 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 14, 2025
Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 14, 2025
Intimation Of Grant Of ESOPNov 14, 2025
Board Meeting Intimation for Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 10, 2025
Board Meeting Intimation for The Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 07, 2025
INTIMATION OF WARNING LETTER ISSUED BY THE STOCK EXCHANGES.Oct 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Closure of Trading WindowSep 26, 2025
Approval Of JHS SVENDGAARD LABORATORIES LIMITED - EMPLOYEE STOCK OPTION SCHEME 2025Sep 22, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 22, 2025
Appointment Of Secretarial AuditorSep 22, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sSep 22, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 22, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 20, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 17, 2025
Launch Of 100 Days Campaign Titled Saksham NiveshakSep 12, 2025
Intimation On Dispatch Of Letter Providing Web Link Of Annual Report For Financial Year 2024-25.Sep 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Reg. 34 (1) Annual Report.Aug 28, 2025
Notice Of 21St Annual General Meeting Of The Company.Aug 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesAug 21, 2025
Board Meeting Outcome for Considered And Approved The JHS Svendgaard Laboratories Employee Stock Option Scheme-2025Aug 21, 2025
Board Meeting Intimation for Considering And Approving The JHS Svendgaard Laboratories Employee Stock Option Scheme - 2025 (Scheme).Aug 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 12, 2025
Un-Audited Financial Result For Quarter Ended 30Th June 2025Aug 12, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 12, 2025
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 30Th June 2025Aug 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Special Window For Re-Lodgement Of Transfer Requests Of Physical SharesJul 07, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 01, 2025
Announcement under Regulation 30 (LODR)-CessationJul 01, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On July 01 2025Jul 01, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 25, 2025
Closure of Trading WindowJun 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 24, 2025

Technical Indicators

RSI(14)
Neutral
44.02
ATR(14)
Less Volatile
0.79
STOCH(9,6)
Oversold
12.68
STOCH RSI(14)
Oversold
9.19
MACD(12,26)
Bearish
-0.09
ADX(14)
Weak Trend
16.60
UO(9)
Bearish
34.73
ROC(12)
Downtrend And Accelerating
-10.25
WillR(14)
Oversold
-96.19